Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Montrose Environmental Group Inc is a waste management business based in the US. Montrose Environmental Group shares (MEG) are listed on the NYSE and all prices are listed in US Dollars. Montrose Environmental Group employs 2,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$64.84|
|52-week range||$24.93 - $68.65|
|50-day moving average||$59.35|
|200-day moving average||$53.25|
|Wall St. target price||$61.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.18|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||3.74%|
|1 month (2021-09-24)||-3.22%|
|3 months (2021-07-23)||28.86%|
|6 months (2021-04-23)||23.36%|
|1 year (2020-10-23)||134.33%|
|2 years (2019-10-20)||N/A|
|3 years (2018-10-20)||N/A|
|5 years (2016-10-20)||N/A|
Valuing Montrose Environmental Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Montrose Environmental Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Montrose Environmental Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $61 million.
The EBITDA is a measure of a Montrose Environmental Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$463.5 million|
|Operating margin TTM||4.19%|
|Gross profit TTM||$112.8 million|
|Return on assets TTM||1.88%|
|Return on equity TTM||-20.49%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
There are currently 1.5 million Montrose Environmental Group shares held short by investors – that's known as Montrose Environmental Group's "short interest". This figure is 46.7% up from 990,102 last month.
There are a few different ways that this level of interest in shorting Montrose Environmental Group shares can be evaluated.
Montrose Environmental Group's "short interest ratio" (SIR) is the quantity of Montrose Environmental Group shares currently shorted divided by the average quantity of Montrose Environmental Group shares traded daily (recently around 347530.14354067). Montrose Environmental Group's SIR currently stands at 4.18. In other words for every 100,000 Montrose Environmental Group shares traded daily on the market, roughly 4180 shares are currently held short.
However Montrose Environmental Group's short interest can also be evaluated against the total number of Montrose Environmental Group shares, or, against the total number of tradable Montrose Environmental Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Montrose Environmental Group's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Montrose Environmental Group shares in existence, roughly 60 shares are currently held short) or 0.0605% of the tradable shares (for every 100,000 tradable Montrose Environmental Group shares, roughly 61 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Montrose Environmental Group.
Find out more about how you can short Montrose Environmental Group stock.
We're not expecting Montrose Environmental Group to pay a dividend over the next 12 months.
Montrose Environmental Group, Inc. operates as an environmental services company in the United States. The company operates in three segments: Assessment, Permitting and Response; Measurement and Analysis; and Remediation and Reuse. The Assessment, Permitting and Response segment provides scientific advisory and consulting services to support environmental assessments, environmental emergency response and recovery, toxicology consulting and environmental audits and permits for current operations, facility upgrades, new projects, decommissioning projects, and development projects. Its technical advisory and consulting services include regulatory compliance support and planning, environmental, and ecosystem and toxicological assessments and support during responses to environmental disruptions. The Measurement and Analysis segment tests and analyzes air, water, and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna, and human health. Its services include source and ambient air testing and monitoring, leak detection, and advanced analytical laboratory services, such as air, storm water, wastewater, and drinking water analysis.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.